Cargando…
Current landscape and perspective of oncolytic viruses and their combination therapies
Oncolytic virotherapy has become an important strategy in cancer immunotherapy. Oncolytic virus (OV) can reshape the tumor microenvironment (TME) through its replication-mediated oncolysis and transgene-produced anticancer effect, inducing an antitumor immune response and creating favorable conditio...
Autores principales: | Su, Yinghan, Su, Changqing, Qin, Lunxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472052/ https://www.ncbi.nlm.nih.gov/pubmed/36095879 http://dx.doi.org/10.1016/j.tranon.2022.101530 |
Ejemplares similares
-
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
por: Su, Yinghan, et al.
Publicado: (2022) -
The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
por: Bernstock, Joshua D., et al.
Publicado: (2021) -
Clinical landscape of oncolytic virus research in 2020
por: Macedo, Nicholas, et al.
Publicado: (2020) -
Oncolytic virus therapy in cancer: A current review
por: Santos Apolonio, Jonathan, et al.
Publicado: (2021) -
Perspectives on immunotherapy via oncolytic viruses
por: Reale, Alberto, et al.
Publicado: (2019)